Precision Medicine

The experts have weighed in. These are the healthtech companies that won 2017.

Why Frost & Sullivan expects the genome-editing technology to be a financial boon.

State-level privacy policies have a substantial impact on incidence of genetic testing, according to a new study.

Costco co-founder Jeffrey Brotman died in August, but friend says the new institute will be a lasting treatment to his generosity.

DNA tests may be selling well in advance of the holidays. This week Senator Chuck Schumer cautioned about how they may use consumer genetic info.

As therapies like Kymriah and Yescarta transform medicine, how can hospitals take advantage of analytics to improve processes and patient outcomes?

The ambitious precision medicine initiative looks to sequence 1 million Americans to inform public health.

In addition to the approval, the agency announced that it is streamlining the review process for NGS tumor tests.

“I know of no other health system with such dedication to putting patients and their health first," the new Initiative's director said.

“We need to use data better,” the billionaire wrote in a blog post announcing a huge investment.

For centuries, population-based evidence has laid the foundation of healthcare. Precision medicine will change that.

The testing company also stated that it raised $65 million in an ongoing funding round.

“With the genomic revolution...it’s increasingly important for providers to have a trusted data partner, and that is why MSK chose Cota.”

This windfall marks the third for a genomics company since Friday.

The genetic testing company celebrated its birthday in style, adding a new board member and a huge investment.

The move could be a massive boon for the burgeoning industry.

Children’s Hospital of Philadelphia and the next-generation sequencing firm analyzed 1,000 genomes in under 3 hours.

The "new era of personalized cancer therapy” is here: effective, novel, and expensive.

The buyer touted the lab company's "unique epigenetic technology and expertise."

Curtis Hanson, MD, sat down to discuss the role of laboratory testing in the pursuit of value-based care.

The American public is interested in consumer DNA testing, but lacking in knowledge about genetics and privacy.

Precision Medicine Group today launched its Precision Value & Health initiative to try to find ways to address that question.

The unit will be capable of producing up to a billion genetically-modified mosquito eggs per week.

LifeMine champions its “genomically-enabled drug discovery engine” that combines artificial intelligence with synthetic biology.

“Sometimes we realize, 'Watson got that one right and we got it wrong," one of its trainers at MSKCC said. Still, it has work to do.

The FDA, for the first time, approved a gene therapy with a good chance of bringing remission for young cancer patients.

"We're in Silicon Valley...if we were in this for the money, there are a lot of other things we could be doing, everyone at this company. The reason we're here is the impact on patients."

The "C-Suite" is in quotes because Jonathan Hirsch settles for just being the Founder and President of his company, Syapse

The firms utilized everything from novel devices to advanced analytics to dogs.

"Whether such artificial-intelligence systems are ‘smarter’ than human practitioners makes for a stimulating debate—but is largely irrelevant," they write.